Advent Capital Management BIOMARIN PHARMACEUTICAL Transaction History

Advent Capital Management

106,000

Previous 108,000 1.85%

Previous $0 NaN%

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	N/A	-2,000 Reduced 1.85%	106,000 $0
Q3 2024 Nov 13, 2024	SELL	N/A	-38,000 Reduced 26.03%	108,000 $0
Q2 2024 Aug 13, 2024	SELL	N/A	-29,738,000 Reduced 99.51%	146,000 $0
Q1 2024 May 14, 2024	SELL	N/A	-1,538,000 Reduced 4.89%	29,884,000 $0
Q4 2023 Feb 13, 2024	SELL	N/A	-8,390,000 Reduced 21.07%	31,422,000 $0
Q3 2023 Nov 13, 2023	BUY	N/A	4,117,000 Added 11.53%	39,812,000 $0
Q2 2023 Aug 11, 2023	BUY	N/A	10,475,000 Added 41.53%	35,695,000 $0
Q1 2023 May 12, 2023	SELL	N/A	-6,844,000 Reduced 21.34%	25,220,000 $0
Q4 2022 Feb 14, 2023	SELL	N/A	-1,470,000 Reduced 4.38%	32,064,000 $0
Q3 2022 Nov 14, 2022	SELL	N/A	-3,993,000 Reduced 10.64%	33,534,000 $33.5 Million
Q2 2022 Aug 15, 2022	SELL	N/A	-7,576,000 Reduced 16.8%	37,527,000 $37.5 Million
Q1 2022 May 13, 2022	BUY	N/A	1,598,000 Added 3.67%	45,103,000 $45.3 Million
Q4 2021 Feb 14, 2022	SELL	N/A	-26,866,000 Reduced 38.18%	43,505,000 $45.4 Million
Q3 2021 Nov 15, 2021	SELL	N/A	-281,000 Reduced 0.4%	70,371,000 $70 Million
Q2 2021 Aug 16, 2021	BUY	N/A	70,652,000 New	70,652,000 $71.2 Million

Get notified when there are updates to the investment portfolio of Advent Capital Management , based on Form 13F filings with the SEC.

Stay updated on Advent Capital Management with notifications on news.